Updates are available Correction dated 2025-07-14
Click to view Correction: https://doi.org/10.1038/s41416-025-03095-1
-
Authors
Sorbye, Halfdan https://orcid.org/0000-0002-7132-6214
Hjortland, Geir Olav
Vestermark, Lene Weber
Ladekarl, Morten https://orcid.org/0000-0002-0182-1228
Svensson, Johanna
Sundlöv, Anna
Janson, Eva Tiensuu
Garresori, Herish
Hofsli, Eva
Kersten, Christian
Elvebakken, Hege https://orcid.org/0000-0001-7458-4836
Pfeiffer, Per
Morken, Siren https://orcid.org/0009-0003-8676-772X
Assmus, Jorg
Lothe, Inger Marie Bowitz
Tabaksblat, Elizaveta
Knigge, Ulrich
Couvelard, Anne
Perren, Aurel
Langer, Seppo W.
- License Information
-
More Information
Article History
Received: 27 January 2025
Revised: 24 April 2025
Accepted: 1 May 2025
First Online: 17 May 2025
Change Date: 23 June 2025
Change Type: Update
Change Details: The original online version of this article was revised: an error was found in the descriptive text for Table 2; the article originally stated “Median PFS/OS (range)”, but the correct description is “Median PFS/OS (95%CI)”.
Change Date: 14 July 2025
Change Type: Correction
Change Details: A Correction to this paper has been published:
Change Details: https://doi.org/10.1038/s41416-025-03095-1
Competing interests
: ML achieved an unrestricted grant from Scandion Oncology, Denmark. All other authors have declared no conflicts of interest.
: The study was conducted according to the Declaration of Helsinki and approved by ethics committees in Norway (REK-vest-2012/940), Sweden (REC-Uppsala-Dnr-2012/285) and Denmark (Region-Hovedstaden-H-4-2012-108). All patients signed written informed consent.
